Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Attention deficit disorders

Study promotes digital help for adults with ADHD

Digital health experts at Flinders University are developing a mobile self-monitoring app model to assist adults with Attention-Deficit Hyperactivity Disorder (ADHD) take a more pro-active role in their "wellness journey."

page 2 from 40